Close Menu

NEW YORK (360Dx) – Taiwan-based Sofiva Genomics today announced that it has established its first subsidiary in Bangkok.

Sofiva offers prenatal screening, neonatal screening, personalized genetic testing, and cancer screening, it said. Additionally, the Thai subsidiary will offer testing for spinal muscular atrophy screening and fragile X syndrome screening.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.


Ribosomal ribonucleic acid (rRNA) accounts for up to 99 percent of the total RNA depending on the cell type. 


This webinar will provide an overview of polygenic risk scores, which aggregate dozens of genetic variants that have been linked to disease risk in genome-wide association studies (GWAS) into a single score.

Sponsored by

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect.